• 624 Citations
  • 12 h-Index
20052018
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2012 PhD, Institute of Clinical Medicine, National Cheng Kung University

Experience

  • 2005.7~Present Attending Physician, Department of Internal Medicine, NCKUH
  • 2013.2~2015.8 Clinical Assistant professorr/Department of Internal Medicine, NCKU
  • 2015.8~present Assistant Professor/Institute of Clinical Medicine, NCKU

Research Interests

  • Clinical Oncology
  • Anti-Cancer Pharmacology
  • DNA Repair and Anti-Oxidant Stress in Oncology
  • Cellular Resistance to Anti-Cancer Therapy and its Clinical Application

Fingerprint Dive into the research topics where Wen-Pin Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Lung Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
STAT3 Transcription Factor Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Malignant Pleural Effusion Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2018

Research Output 2005 2018

  • 624 Citations
  • 12 h-Index
  • 25 Article
  • 2 Letter

Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy

Yen, C. C., Su, H-C., Chu, C-Y., Lai, S. J., Yan, J. J., Su, W-P. & Su, W-C., 2018 Jun 1, In : Lung Cancer. 120, p. 149-151 3 p.

Research output: Contribution to journalLetter

Polyneuropathies
Lung Neoplasms
Therapeutics
pembrolizumab
3 Citations (Scopus)

Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways

Su, W-P., Ho, Y. C., Wu, C. K., Hsu, S. H., Shiu, J. L., Huang, J. C., Chang, S-B., Chiu, W-T., Hung, J-J., Liu, T., Wu, W-S., Wu, P. Y., Su, W-C., Chang, J-Y. & Liaw, H-J., 2017 Dec 1, In : Scientific reports. 7, 1, 3879.

Research output: Contribution to journalArticle

Fanconi Anemia
Recombinational DNA Repair
Cisplatin
Fanconi Anemia Complementation Group D2 Protein
Genes
51 Citations (Scopus)
docetaxel
Platinum
Placebos
Carcinoma
Therapeutics
2 Citations (Scopus)

Combined interactions of plant homeodomain and chromodomain regulate NuA4 activity at DNA double-strand breaks

Su, W-P., Hsu, S. H., Chia, L. C., Lin, J. Y., Chang, S-B., Jiang, Z. D., Lin, Y. J., Shih, M. Y., Chen, Y. C., Chang, M. S., Yang, W. B., Hung, J-J., Hung, P. C., Wu, W-S., Myung, K. & Liaw, H-J., 2016 Jan 1, In : Genetics. 202, 1, p. 77-92 16 p.

Research output: Contribution to journalArticle

Double-Stranded DNA Breaks
Acetylation
Histones
Mutation
Bleomycin
11 Citations (Scopus)

Huntingtin-interacting protein-1 is an early-stage prognostic biomarker of lung adenocarcinoma and suppresses metastasis via AKT-mediated epithelial-mesenchymal transition

Hsu, C. Y., Lin, C. H., Jan, Y. H., Su, C. Y., Yao, Y. C., Cheng, H. C., Hsu, T. I., Wang, P. S., Su, W-P., Yang, C. J., Huang, M. S., Calkins, M. J., Hsiao, M. & Lu, P-J., 2016 Apr 15, In : American Journal of Respiratory and Critical Care Medicine. 193, 8, p. 869-880 12 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
Biomarkers
Neoplasm Metastasis
Non-Small Cell Lung Carcinoma
Adenocarcinoma